Beneficial effect of both tranexamic acid and aprotinin on blood loss reduction in reoperative valve replacement surgery

Circulation

Volumn 96, Issue 9 SUPPL., 1997, Pages

  Jamieson, W R E ^a   Dryden, P J ^a   O'Connor, J P ^a   Sadeghi, H ^a   Ansley, D M ^a   Merrick, P M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Antifibrinolytic therapy; Blood loss; Cardiac valve reoperative surgery

Indexed keywords

APROTININ; TRANEXAMIC ACID;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; FEMALE; HEART VALVE SURGERY; HUMAN; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REOPERATION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; APROTININ; BLOOD LOSS, SURGICAL; DOUBLE-BLIND METHOD; FEMALE; HEART VALVES; HEMOSTATICS; HUMANS; MALE; MIDDLE AGED; REOPERATION; TRANEXAMIC ACID;

EID: 0342762022     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Royston D, Bidstrup BP, Taylor KM, Sapsford RN. Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet. 1987;II:1289-1291.
2. Biagini A, Comite C, Russo V, Salerno ML, Gemignani R, Pardelli S, Baccellini M, Baroni M, Pugliese S, Maffei S, Paoli F, Scioti G, Verunelli F, Salvatore L. High-dose aprotinin to reduce blood loss in patients undergoing redo open heart surgery. Acta Anaesthesiol Belg. 1992;43:181-186.
3. Bidstrup BP, Royston D, Sapsford RN, Taylor KM. Reduction in blood loss use after cardiopulmonary bypass with high dose aprotinin (Trasylol). J Thorac Cardiovasc Surg. 1989;97:364-372.
4. Carrel T, Bauer E, Garcia E, von Segesser L, Niederhauser U, Schonbeck M, Laske A, Turina M. Reduction of postoperative blood loss and donor blood use in heart surgery with aprotinin: experience with various dosages. Helv Chir Acta. 1991;58:365-378.
5. Dietrich W, Barankay A, Hahnel C, Richter JA. High-dose aprotinin in cardiac surgery: three years' experience in 1,784 patients. J Cardiothorac Vasc Anesth. 1992;6:324-327.
6. Gerometta P, Antona C, Parolari A, Fratto P, Alamanni F, Spirito R, Arena V, Biglioli P. Retrospective study of the efficacy of aprotinin in heart valve surgery in adults. Minerva Cardioangiol. 1995;43:47-54.
7. Havel M, Teufelsbauer H, Knobl P, Dalmatiner R, Jaksch P, Zwolfer W, Muller M, Vukovich T. Effect of intraoperative aprotinin administration on postoperative bleeding in patients undergoing cardiopulmonary bypass operation. J Thorac Cardiovasc Surg. 1991;101:968-972.
8. Levy JH, Pifarre R, Schaff HV, Horrow JC, Albus R, Spiess B, Rosengart TK, Murray J, Clark RE, Smith P, Nadel A, Bonney SL, Kleinfield R. A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. Circulation. 1995;92:2236-2244.
9. Hardy JF, Desroches J, Belisle S, Perrault J, Carrier M, Robitaille D. Low-dose aprotinin infusion is not clinically useful to reduce bleeding and transfusion of homologous blood products in high-risk cardiac surgical patients. Can J Anaesth. 1993;40:625-631.
10. Kawasuji M, Ueyama K, Sakakibara N, Tedoriya T, Matsunaga Y, Misaki T, Watanabe Y. Effect of low-dose aprotinin on coagulation and fibrinolysis in cardiopulmonary bypass. Ann Thorac Surg. 1993;55:1205-1209.
11. Nakamura T, Shimamoto M, Yamazaki F, Fujita S, Yoshimura T, Ueno T, Oyanagi H, Shinozaki T. Effects of "low dose" aprotinin in open heart surgery and its plasma concentration. Nippon Kyobu Geka Gakkai Zasshi. 1994;42:188-193.
12. Schonberger JP, Woolley S, Tavilla G, Berreklouw E, Bredee JJ, Mashhour YA, Van Straten BH, Bavinck JH, Frietman PA, Everts PA, Wildevuur ChR. Efficacy and safety of a blood conservation program including low-dose aprotinin in routine myocardial revascularization. J Cardiovasc Surg. 1996;37:35-44.
13. Coffey A, Pittmam J, Halbrook H, Fehrenbacher J, Beckman D, Hormuth D. The use of tranexamic acid to reduce postoperative bleeding following cardiac surgery: a double-blind randomized trial. Am Surg. 1995;61:566-568.
14. Horrow JC, Hlavacek J, Strong MD, Collier W, Brodsky I, Goldman SM, Goel IP. Prophylactic tranexamic acid decreases bleeding after cardiac operations. J Thorac Cardiovasc Surg. 1990;99:70-74.
15. Horrow JC, Van Riper DF, Strong MD, Grunewald KE, Parmet JL. The dose-response relationship of tranexamic acid. Anesthesiology. 1995;82:383-392.
16. Boughenou F, Madi-Jebara S, Massonnet-Castel S, Benmosbah L, Carpentier A, Cousin MT. Fibrinolytic inhibitors and prevention of bleeding in cardiac valve surgery: comparison of tranexamic acid and high-dose aprotinin. Arch Mal Coeur Vaiss. 1995;88:363-370.
17. Corbeau JJ, Monrigal JP, Jacob JP, Cottineau C, Moreau X, Bukowski JG, Subayi JB, Delhumeau A. Comparison of effects of aprotinin and tranexamic acid on blood loss in heart surgery. Ann Fr Anesth Reanim. 1995;14:154-161.
18. Karski JM, Teasdale SJ, Norman PH, Carroll JA, Weisel RD, Glynn MF. Prevention of postbypass bleeding with tranexamic acid and epsilon-aminocaproic acid. J Cardiothorac Vasc Anesth. 1993;7:431-435.
19. Pugh SC, Wielogorski AK. A comparison of the effects of tranexamic acid and low-dose aprotinin on blood loss and homologous blood usage in patients undergoing cardiac surgery. J Cardiothorac Vasc Anesth. 1995;9:240-244.
20. Taylor KM. Perioperative approaches to coagulation defects. Ann Thorac Surg. 1993;56(suppl 5):S78-S82.
21. Dryden PJ, O'Connor JP, Jamieson WRE, Reid I, Ansley D, Sadeghi H, Burr LH, Munro AI, Merrick PM. Tranexamic acid reduces blood loss and transfusion in reoperative cardiac surgery. Can J Anaesth. 1997;44:934-941.